Finance

Lists
VKTX:NASDAQ
Viking Therapeutics Inc
$33.86
-2.90%
(-1.01) 1D
$33.80
-0.18% (-0.060)
After hours
Closed: Jul 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VKTX...
Open
$34.67
High
$34.81
Low
$32.72
Mkt. cap
3.93B
Avg. vol.
2.59M
Volume
2.33M
52-wk high
$43.15
52-wk low
$22.96
EPS
-$4.15
Beta
0.66
Shares outstanding
116.11M
No. of employees
59
Open
$34.67
High
$34.81
Low
$32.72
Mkt. cap
3.93B
Avg. vol.
2.59M
Volume
2.33M
52-wk high
$43.15
52-wk low
$22.96
EPS
-$4.15
Beta
0.66
Shares outstanding
116.11M
No. of employees
59
News stories
From sources across the web
About Viking Therapeutics Inc
CEOBrian Lian
Employees59
Founded2012
Headquarters-
SectorBiotechnology
Websitevikingtherapeutics.com
Analyst ratings
Based on 13 analysts giving stock ratings to VKTX in the past 3 months
Strong buy
Buy
13
Hold
0
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for VKTX in the last 3 months.
Highest
Current $33.86
$125.00 (+269.17%)
Average
$92.91 (+174.39%)
Lowest
$70.00 (+106.73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
$95.00
+180.6%
07/24/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
07/16/2026
Edward Nash
Canaccord Genuity
Buy
Maintained
$107.00
+216%
07/15/2026
Biren Amin
Piper Sandler
Buy
Maintained
$71.00
+109.7%
07/07/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$100.00
+195.3%
07/01/2026
Naz Rahman
Maxim Group
Buy
Reiterated
$70.00
+106.7%
06/25/2026
William Wood
B. Riley Securities
Buy
Reiterated
$85.00
+151%
06/25/2026
Michael Ulz
Morgan Stanley
Buy
Maintained
$95.00
+180.6%
06/24/2026
Ryan Deschner
Raymond James
Buy
Maintained
-
-
06/24/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$102.00
+201.2%
06/24/2026
Daniel Brims
Lake Street
Buy
Initiated
$89.00
+162.8%
05/28/2026
Joon Lee
Truist Financial
Buy
Initiated
$83.00
+145.1%
05/27/2026
Gregory Renza
Truist Financial
Buy
Initiated
$83.00
+145.1%
05/27/2026
Jeet Mukherjee
BTIG
Buy
Reiterated
$125.00
+269.2%
05/01/2026
Roger Song
Jefferies
Buy
Maintained
$101.00
+198.3%
02/12/2026
Unknown Analyst
B. Riley Securities
Buy
Initiated
$85.00
+151%
02/12/2026
Hardik Parikh
J.P. Morgan
Buy
Maintained
$75.00
+121.5%
02/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
60.15M
89.95M
153.46M
150.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.42M
8.61M
11.28M
13.98M
Operating expense
74.57M
98.56M
164.74M
164.12M
Total operating expenses
74.57M
98.56M
164.74M
164.12M
Operating income
-74.57M
-98.56M
-164.74M
-164.12M
Other non operating income
-
-
-
-
EBT including unusual items
-65.56M
-90.79M
-157.66M
-158.32M
EBT excluding unusual items
-65.56M
-90.80M
-157.70M
-158.32M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-65.56M
-90.79M
-157.66M
-158.32M
Net profit margin
-
-
-
-
Earnings per share
-0.58
-0.81
-1.38
-1.37
Interest and investment income
9.03M
7.77M
7.04M
5.80M
Interest expense
-24.00K
-8.00K
-
-
Net interest expenses
9.01M
7.76M
7.04M
5.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer